The stock market indices had a very mixed, sloppy session, and finished the day on a sour note, with the S&P 500 unchanged today. The day started out with a move down, a very strong rally in the morning ensured, reaching a new all-time high on the 5050 Nasdaq 100. The S&P 500 couldn’t get back to Friday’s double-top high at 22.82, reaching 2279 today, and then rolled over to 2269. The Dow closed down, the S&P 500 closed flat, while the Nasdaq 100 closed slightly in the plus column.
Net on the day, the Dow was down 32.16 at 19,855.22, 100 points off the high. The S&P 500 was up .01 at 2268.91, 11 points off the high and 4 points off the low. The Nasdaq 100 was up 10.27 at 5035.17, 14 points off the high.
Advance-declines were 18 to 11 positive on the New York Stock Exchange, and 9 to 5 positive the Nasdaq. Up/down volume was 4 to 3 positive on New York, total volume of 3.5 billion shares traded. The Nasdaq traded 1.7 billion shares and had a 10 to 7 positive volume ratio.
TheTechTrader.com board was mixed. Priceline.com (PCLN) was up 5.61 to 1535.25, Apple Inc. (AAPL) up 12 cents 119.11, but Alphabet Inc. (GOOG) dropped 1.86 to 804.79, Amazon.com, Inc. (AMZN) gave back 1.02 to 795.90, and Netflix, Inc. (NFLX) closed down 1.06 to 129.89.
Baidu, Inc. (BIDU) gained 3.15 to 180.31, Facebook, Inc. (FB) fell 55 cents to 124.35, and First Solar, Inc. (FSLR) closed negative by 18 cents to 33.39.
Tesla Motors, Inc. (TSLA) lost 1.41 to 229.87.
Other stocks to the upside included CoLucid Pharmaceuticals, Inc. (CLCD), up 1.55 to 35.00, Exelixis, Inc. (EXEL) up 1.33 to 18.91, U.S. Concrete, Inc. (USCR) 1.15 to 61.00, and United States Steel Corp. (X) 1.89 to 35.50.
On the downside, there were very fractional losers on our board today.
Checking TheTechTrader.com percent-gain leaderboard, Biocept, Inc. (BIOC) climbed 79 cents, or 77 1/2%, to 1.81, on 21.7 million shares traded.
ImmunoCellular Therapeutics, Ltd. (IMUC), after announcing management changes, popped 2.02, or 93%, to 4.20, on 1.4 million shares traded. GenVec, Inc. (GNVC) gained 3.82, or 77%, to 8.79, on 17 million shares traded.
Signal Genetics, Inc. (SGNL), on merger talks, exploded 12.69, or 265%, to 17.48, on 1.2 million shares traded.
Small biotech stocks and thinly-traded stocks were flying high today, and that’s not a good sign for the market, in my opinion. That said, they had an incredible day today, and the list of biotech stocks that did well today is many.
Stepping back and reviewing the hourly chart patterns, after opening lower, and rallying sharply in the morning, the indices backed off in the afternoon and closed lower on the Dow, flat on the S&P 500, and up a little on the Nasdaq 100.
It was a quiet, mixed session, and consolidation day, if nothing else.
Let’s see what happens tomorrow.
In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.